INTRODUCTION / AIM
Oral ingestion of 150 mg/kg of monosodium glutamate (MSG) by healthy subjects has been shown to cause headaches. We investigated whether systemic administration of MSG is capable of exciting and/or sensitizing spinal trigeminal subnucleus caudalis (SpVc) neurons with dural receptive fields as part of its mechanism to induce headache.
METHODS
A total of 21 male and 19 female Sprague-Dawley rats were used. Single unit electrophysiological recordings of SpVc neurons that responded to mechanical stimulation of the dura were undertaken. Intravenous MSG (50mg/kg) was administered alone or in combination with the NMDA receptor antagonist 2-amino-5-phosphono-valerate (APV; 5, 50 mg/kg). An electronic von Frey hair was used to assess mechanical threshold (MT).
RESULTS
MSG increased spontaneous action potential discharges. This was attenuated by coadministering 5 mg/kg APV (P>0.05, 2-way ANOVA on RANKS). MSG decreased the MT by 5.7±6.5%. Co-administration of APV with MSG also attenuated this MSG-induced mechanical sensitization in a dose dependent manner (P>0.05, 2-way ANOVA on RANKS). There was no sex-related difference in these effects.
DISCUSSION / CONCLUSIONS
Systemically administered MSG excites and mechanically sensitizes dural afferent fibres through activation of peripheral NMDA receptors. Peripherally restricted NMDA receptor antagonists may be useful in the treatment of headache.
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